Rosenecker Lab

Research topics

^{• Gene therapy of pulmonary diseases, e.g. Cystic Fibrosis, Surfactant-Protein B deficiency}
^{• Design and synthesis of non-viral carriers for nucleic acids}
^{•Characterization of nanocomplexes formed by block copolymers and mRNA/pDNA}
^{•In vitro evaluation of mRNA/pDNA containing nanocomplexes and mechanism study}
^{•In vivo evaluation of above mentioned nanocomplexes and their ability of correcting cystic fibrosis}

Prof. Dr. Joseph Rosenecker
✉ joseph.rosenecker@med.uni-muenchen.de
☎ +49 89 4400 57711
Dr. rer. nat. Giovana Bampi
Post-Doctoral Researcher
✉ giovana.bampi@med.uni-muenchen.de
☎ 089-4400-57974

Dr. Xiaoyan Ding
Post-Doctoral Researcher
✉ xiaoyan.ding@med.uni-muenchen.de
☎ 089-4400-57974

Dandan Zhang
Doctoral Researcher
✉ dandan.zhang@med.uni-muenchen.de
☎ 089-4400-57974
Publications

https://pubmed.ncbi.nlm.nih.gov/?term=Rosenecker+J

Patents

Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cell; US2003125242; 2002; Rudolph C, Plank C, Rosenecker J, Ritter W.
Magnet-field controlled active substance transfer for aerosol therapy; Patent ID: US8567410; 2006; Rudolph C, Rosenecker J.
Synthetic Compound for Improving Efficiency of Transfection; US2019083654; 2017; Rosenecker J; Guan S
Prof. Dr. Joseph Rosenecker

University of Munich, Department of Pediatrics Dr. von Haunersches Children's Hospital

Lindwurmstraße 4
80337 Munich
+49 89 4400 57711

Rosenecker Lab

Research topics

• Gene therapy of pulmonary diseases, e.g. Cystic Fibrosis, Surfactant-Protein B deficiency

• Design and synthesis of non-viral carriers for nucleic acids

•Characterization of nanocomplexes formed by block copolymers and mRNA/pDNA

•In vitro evaluation of mRNA/pDNA containing nanocomplexes and mechanism study

•In vivo evaluation of above mentioned nanocomplexes and their ability of correcting cystic fibrosis

Prof. Dr. Joseph Rosenecker

Publications

Patents

^{• Gene therapy of pulmonary diseases, e.g. Cystic Fibrosis, Surfactant-Protein B deficiency}

^{• Design and synthesis of non-viral carriers for nucleic acids}

^{•Characterization of nanocomplexes formed by block copolymers and mRNA/pDNA}

^{•In vitro evaluation of mRNA/pDNA containing nanocomplexes and mechanism study}

^{•In vivo evaluation of above mentioned nanocomplexes and their ability of correcting cystic fibrosis}